Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Mar;109(Suppl 1):69–75. doi: 10.1289/ehp.01109s169

The value of plants used in traditional medicine for drug discovery.

D S Fabricant 1, N R Farnsworth 1
PMCID: PMC1240543  PMID: 11250806

Abstract

In this review we describe and discuss several approaches to selecting higher plants as candidates for drug development with the greatest possibility of success. We emphasize the role of information derived from various systems of traditional medicine (ethnomedicine) and its utility for drug discovery purposes. We have identified 122 compounds of defined structure, obtained from only 94 species of plants, that are used globally as drugs and demonstrate that 80% of these have had an ethnomedical use identical or related to the current use of the active elements of the plant. We identify and discuss advantages and disadvantages of using plants as starting points for drug development, specifically those used in traditional medicine.

Full Text

The Full Text of this article is available as a PDF (323.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker J. T., Borris R. P., Carté B., Cordell G. A., Soejarto D. D., Cragg G. M., Gupta M. P., Iwu M. M., Madulid D. R., Tyler V. E. Natural product drug discovery and development: new perspectives on international collaboration. J Nat Prod. 1995 Sep;58(9):1325–1357. doi: 10.1021/np50123a003. [DOI] [PubMed] [Google Scholar]
  2. Bhakuni D. S., Dhar M. L., Dhar M. M., Dhawan B. N., Gupta B., Srimal R. C. Screening of Indian plants for biological activity. 3. Indian J Exp Biol. 1971 Jan;9(1):91–102. [PubMed] [Google Scholar]
  3. Bhakuni D. S., Dhar M. L., Dhar M. M., Dhawan B. N., Mehrotra B. N. Screening of Indian plants for biological activity. II. Indian J Exp Biol. 1969 Oct;7(4):250–262. [PubMed] [Google Scholar]
  4. Bierer D. E., Dubenko L. G., Zhang P., Lu Q., Imbach P. A., Garofalo A. W., Phuan P. W., Fort D. M., Litvak J., Gerber R. E. Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta. J Med Chem. 1998 Jul 16;41(15):2754–2764. doi: 10.1021/jm970735n. [DOI] [PubMed] [Google Scholar]
  5. Bierer D. E., Fort D. M., Mendez C. D., Luo J., Imbach P. A., Dubenko L. G., Jolad S. D., Gerber R. E., Litvak J., Lu Q. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities. J Med Chem. 1998 Mar 12;41(6):894–901. doi: 10.1021/jm9704816. [DOI] [PubMed] [Google Scholar]
  6. Bonet M. A., Parada M., Selga A., Vallès J. Studies on pharmaceutical ethnobotany in the regions of L'Alt Empordà and Les Guilleries (Catalonia, Iberian Peninsula). J Ethnopharmacol. 1999 Dec 15;68(1-3):145–168. doi: 10.1016/s0378-8741(99)00083-5. [DOI] [PubMed] [Google Scholar]
  7. Carney J. R., Krenisky J. M., Williamson R. T., Luo J., Carlson T. J., Hsu V. L., Moswa J. L. Maprouneacin, a new daphnane diterpenoid with potent antihyperglycemic activity from Maprounea africana. J Nat Prod. 1999 Feb;62(2):345–347. doi: 10.1021/np980356c. [DOI] [PubMed] [Google Scholar]
  8. Clark A. M. Natural products as a resource for new drugs. Pharm Res. 1996 Aug;13(8):1133–1144. doi: 10.1023/a:1016091631721. [DOI] [PubMed] [Google Scholar]
  9. Cragg G. M., Boyd M. R., Cardellina J. H., 2nd, Newman D. J., Snader K. M., McCloud T. G. Ethnobotany and drug discovery: the experience of the US National Cancer Institute. Ciba Found Symp. 1994;185:178–196. doi: 10.1002/9780470514634.ch13. [DOI] [PubMed] [Google Scholar]
  10. Cragg G. M., Newman D. J., Snader K. M. Natural products in drug discovery and development. J Nat Prod. 1997 Jan;60(1):52–60. doi: 10.1021/np9604893. [DOI] [PubMed] [Google Scholar]
  11. Dhar M. L., Dhar M. M., Dhawan B. N., Mehrotra B. N., Ray C. Screening of Indian plants for biological activity: I. Indian J Exp Biol. 1968 Oct;6(4):232–247. [PubMed] [Google Scholar]
  12. Dhar M. L., Dhar M. M., Dhawan B. N., Mehrotra B. N., Srimal R. C., Tandon J. S. Screening of Indian plants for biological activity. IV. Indian J Exp Biol. 1973 Jan;11(1):43–54. [PubMed] [Google Scholar]
  13. Dhar M. L., Dhawan B. N., Prasad C. R., Rastogi R. P., Singh K. K., Tandon J. S. Screening of Indian plants for biological activity : Part V. Indian J Exp Biol. 1974 Nov;12(6):512–523. [PubMed] [Google Scholar]
  14. Dhawan B. N., Dubey M. P., Mehrotra B. N., Rastogi R. P., Tandon J. S. Screening of Indian plants for biological activity: Part IX. Indian J Exp Biol. 1980 Jun;18(6):594–606. [PubMed] [Google Scholar]
  15. Dhawan B. N., Patnaik G. K., Rastogi R. P., Singh K. K., Tandon J. S. Screening of Indian plants for biological activity: part VI. Indian J Exp Biol. 1977 Mar;15(3):208–219. [PubMed] [Google Scholar]
  16. Douros J., Suffness M. New natural products under development at the National Cancer Institute. Recent Results Cancer Res. 1981;76:153–175. doi: 10.1007/978-3-642-81565-2_14. [DOI] [PubMed] [Google Scholar]
  17. Douros J., Suffness M. The National Cancer Institute's Natural Products Antineoplastic Development Program. Recent Results Cancer Res. 1980;70:21–44. doi: 10.1007/978-3-642-81392-4_3. [DOI] [PubMed] [Google Scholar]
  18. Farnsworth N. R., Akerele O., Bingel A. S., Soejarto D. D., Guo Z. Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965–981. [PMC free article] [PubMed] [Google Scholar]
  19. Farnsworth N. R. Biological and phytochemical screening of plants. J Pharm Sci. 1966 Mar;55(3):225–276. doi: 10.1002/jps.2600550302. [DOI] [PubMed] [Google Scholar]
  20. Farnsworth N. R. Ethnopharmacology and drug development. Ciba Found Symp. 1994;185:42–59. doi: 10.1002/9780470514634.ch4. [DOI] [PubMed] [Google Scholar]
  21. Farnsworth N. R. The role of ethnopharmacology in drug development. Ciba Found Symp. 1990;154:2–21. doi: 10.1002/9780470514009.ch2. [DOI] [PubMed] [Google Scholar]
  22. Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today. 2000 Jul;5(7):294–300. doi: 10.1016/s1359-6446(00)01511-7. [DOI] [PubMed] [Google Scholar]
  23. Kashman Y., Gustafson K. R., Fuller R. W., Cardellina J. H., 2nd, McMahon J. B., Currens M. J., Buckheit R. W., Jr, Hughes S. H., Cragg G. M., Boyd M. R. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem. 1992 Jul 24;35(15):2735–2743. doi: 10.1021/jm00093a004. [DOI] [PubMed] [Google Scholar]
  24. King S. R., Carlson T. J., Moran K. Biological diversity, indigenous knowledge, drug discovery and intellectual property rights: creating reciprocity and maintaining relationships. J Ethnopharmacol. 1996 Apr;51(1-3):45–57. doi: 10.1016/0378-8741(95)01349-0. [DOI] [PubMed] [Google Scholar]
  25. Kinghorn A. D. The discovery of drugs from higher plants. Biotechnology. 1994;26:81–108. doi: 10.1016/b978-0-7506-9003-4.50010-1. [DOI] [PubMed] [Google Scholar]
  26. Loub W. D., Farnsworth N. R., Soejarto D. D., Quinn M. L. NAPRALERT: computer handling of natural product research data. J Chem Inf Comput Sci. 1985 May;25(2):99–103. doi: 10.1021/ci00046a009. [DOI] [PubMed] [Google Scholar]
  27. Luo J., Cheung J., Yevich E. M., Clark J. P., Tsai J., Lapresca P., Ubillas R. P., Fort D. M., Carlson T. J., Hector R. F. Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes. J Pharmacol Exp Ther. 1999 Feb;288(2):529–534. [PubMed] [Google Scholar]
  28. Luo J., Chuang T., Cheung J., Quan J., Tsai J., Sullivan C., Hector R. F., Reed M. J., Meszaros K., King S. R. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). Eur J Pharmacol. 1998 Apr 3;346(1):77–79. doi: 10.1016/s0014-2999(98)00139-3. [DOI] [PubMed] [Google Scholar]
  29. Luo J., Fort D. M., Carlson T. J., Noamesi B. K., nii-Amon-Kotei D., King S. R., Tsai J., Quan J., Hobensack C., Lapresca P. Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent. Diabet Med. 1998 May;15(5):367–374. doi: 10.1002/(SICI)1096-9136(199805)15:5<367::AID-DIA576>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  30. Mebs D. Notes on the traditional use of plants to treat snake bite in northern Papua New Guinea. Toxicon. 2000 Feb;38(2):299–302. doi: 10.1016/s0041-0101(99)00148-8. [DOI] [PubMed] [Google Scholar]
  31. Merzouki A., Ed-derfoufi F., Molero Mesa J Contribution to the knowledge of Rifian traditional medicine. II: Folk medicine in Ksar Lakbir district (NW Morocco). Fitoterapia. 2000 Jun;71(3):278–307. doi: 10.1016/s0367-326x(00)00139-8. [DOI] [PubMed] [Google Scholar]
  32. Ndubani P., Höjer B. Traditional healers and the treatment of sexually transmitted illnesses in rural Zambia. J Ethnopharmacol. 1999 Oct;67(1):15–25. doi: 10.1016/s0378-8741(99)00075-6. [DOI] [PubMed] [Google Scholar]
  33. Newman D. J., Cragg G. M., Snader K. M. The influence of natural products upon drug discovery. Nat Prod Rep. 2000 Jun;17(3):215–234. doi: 10.1039/a902202c. [DOI] [PubMed] [Google Scholar]
  34. Noumi E., Dibakto T. W. Medicinal plants used for peptic ulcer in the Bangangte region, western Cameroon. Fitoterapia. 2000 Aug;71(4):406–412. doi: 10.1016/s0367-326x(00)00144-1. [DOI] [PubMed] [Google Scholar]
  35. Ogura M., Cordell G. A., Quinn M. L., Leon C., Benoit P. S., Soejarto D. D., Farnsworth N. R. Ethnopharmacologic studies. I. Rapid solution to a problem--oral use of Heliopsis longipes--by means of a multidisciplinary approach. J Ethnopharmacol. 1982 Mar;5(2):215–219. doi: 10.1016/0378-8741(82)90045-9. [DOI] [PubMed] [Google Scholar]
  36. Oubré A. Y., Carlson T. J., King S. R., Reaven G. M. From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia. 1997 May;40(5):614–617. doi: 10.1007/s001250050724. [DOI] [PubMed] [Google Scholar]
  37. Phillipson J. D., Anderson L. A. Ethnopharmacology and Western medicine. J Ethnopharmacol. 1989 Feb;25(1):61–72. doi: 10.1016/0378-8741(89)90045-7. [DOI] [PubMed] [Google Scholar]
  38. Pieroni A. Medicinal plants and food medicines in the folk traditions of the upper Lucca Province, Italy. J Ethnopharmacol. 2000 Jun;70(3):235–273. doi: 10.1016/s0378-8741(99)00207-x. [DOI] [PubMed] [Google Scholar]
  39. Rastogi R. P., Dhawan B. N. Research on medicinal plants at the Central Drug Research Institute, Lucknow (India). Indian J Med Res. 1982 Dec;76 (Suppl):27–45. [PubMed] [Google Scholar]
  40. Sherman D. S., Fish D. N. Management of protease inhibitor-associated diarrhea. Clin Infect Dis. 2000 Jun 14;30(6):908–914. doi: 10.1086/313826. [DOI] [PubMed] [Google Scholar]
  41. Shinwari M. I., Khan M. A. Folk use of medicinal herbs of Margalla Hills National Park, Islamabad. J Ethnopharmacol. 2000 Jan;69(1):45–56. doi: 10.1016/s0378-8741(99)00135-x. [DOI] [PubMed] [Google Scholar]
  42. Soejarto D. D. Biodiversity prospecting and benefit-sharing: perspectives from the field. J Ethnopharmacol. 1996 Apr;51(1-3):1–15. doi: 10.1016/0378-8741(95)01345-8. [DOI] [PubMed] [Google Scholar]
  43. Soejarto D. D., Farnsworth N. R. Tropical rain forests: potential source of new drugs? Perspect Biol Med. 1989 Winter;32(2):244–256. doi: 10.1353/pbm.1989.0003. [DOI] [PubMed] [Google Scholar]
  44. Soejarto D. D., Kinghorn A. D., Farnsworth N. R. Potential sweetening agents of plant origin. III. Organoleptic evaluation of Stevia leaf herbarium samples for sweetness. J Nat Prod. 1982 Sep-Oct;45(5):590–599. doi: 10.1021/np50023a013. [DOI] [PubMed] [Google Scholar]
  45. Spjut R. W., Perdue R. E., Jr Plant folklore: a tool for predicting sources of antitumor activity? Cancer Treat Rep. 1976 Aug;60(8):979–985. [PubMed] [Google Scholar]
  46. Suffness M., Douros J. Current status of the NCI plant and animal product program. J Nat Prod. 1982 Jan-Feb;45(1):1–14. doi: 10.1021/np50019a001. [DOI] [PubMed] [Google Scholar]
  47. Turner D. M. Natural product source material use in the pharmaceutical industry: the Glaxo experience. J Ethnopharmacol. 1996 Apr;51(1-3):39–44. doi: 10.1016/0378-8741(95)01348-2. [DOI] [PubMed] [Google Scholar]
  48. Vagelos P. R. Are prescription drug prices high? Science. 1991 May 24;252(5009):1080–1084. doi: 10.1126/science.252.5009.1080. [DOI] [PubMed] [Google Scholar]
  49. Verpoorte R. Pharmacognosy in the new millennium: leadfinding and biotechnology. J Pharm Pharmacol. 2000 Mar;52(3):253–262. doi: 10.1211/0022357001773931. [DOI] [PubMed] [Google Scholar]
  50. Vlietinck A. J., Vanden Berghe D. A. Can ethnopharmacology contribute to the development of antiviral drugs? J Ethnopharmacol. 1991 Apr;32(1-3):141–153. doi: 10.1016/0378-8741(91)90112-q. [DOI] [PubMed] [Google Scholar]
  51. Wall M. E., Wani M. C. Camptothecin and taxol: from discovery to clinic. J Ethnopharmacol. 1996 Apr;51(1-3):239–254. doi: 10.1016/0378-8741(95)01367-9. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES